FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 341:1974-1978 December 23, 1999 Number 26 Next

	Full Text PDF Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

ABSTRACT

Background The use of methotrexate for the treatment of women with tubal ectopic pregnancies is now common practice. However, the clinical and hormonal determinants of the success of this treatment are not known.

Methods We studied 350 women with tubal ectopic pregnancies who were treated with methotrexate intramuscularly according to a single-dose protocol. Pretreatment serum concentrations of human chorionic gonadotropin and progesterone, the size and volume of the gestational mass, fetal cardiac activity, and the presence of fluid (presumably blood) in the peritoneal cavity were correlated with the efficacy of therapy, as defined by resolution of the ectopic pregnancy without the need for surgical intervention.

Results There was no relation between the women's age or parity, the size or volume of the conceptus, or the presence of fluid in the peritoneal cavity and the efficacy of treatment. Among the 320 women in whom treatment was successful (91 percent), the mean (±SD) serum chorionic gonadotropin and progesterone concentrations were 4019±6362 mIU per milliliter and 6.9±6.7 ng per milliliter (21.9±21.3 nmol per liter), respectively, as compared with 13,420± 16,590 mIU per milliliter and 10.2±5.5 ng per milliliter (32.4±17.5 nmol per liter) (P<0.001 and P=0.02) in the 30 women in whom treatment was not successful. Fetal cardiac activity was present in 12 percent of the successfully treated cases and 30 percent of those in which treatment was not successful (P=0.01). Regression analysis revealed the pretreatment serum chorionic gonadotropin concentration to be the only factor that contributed to the failure rate.

Conclusions Among women with tubal ectopic pregnancies, a high serum chorionic gonadotropin concentration is the most important factor associated with failure of treatment with a single-dose methotrexate protocol.

Source Information

From the Division of Gynecology, Department of Obstetrics and Gynecology, University of Tennessee, Memphis.

Address reprint requests to Dr. Lipscomb at Rm. E102, 853 Jefferson Ave., Memphis, TN 38103, or at glipscomb{at}utmem.edu.

Full Text of this Article

Related Letters:

Insurance Payments for Bone Marrow Transplantation in Metastatic Breast Cancer
van Amerongen D.
Extract | Full Text  
N Engl J Med 2000; 342:1138-1139, Apr 13, 2000. Correspondence

This article has been cited by other articles:

• Moon, M. H., Lee, Y. H., Lim, K. T., Yang, J. H., Park, S. H. (2008). Outcome Prediction for Treatment of Tubal Pregnancy Using an Intramuscular Methotrexate Protocol. J Ultrasound Med 27: 1461-1467 [Abstract] [Full Text]  
• Kirk, E., Condous, G., Van Calster, B., Haider, Z., Van Huffel, S., Timmerman, D., Bourne, T. (2007). A validation of the most commonly used protocol to predict the success of single-dose methotrexate in the treatment of ectopic pregnancy. Hum Reprod 22: 858-863 [Abstract] [Full Text]  
• Sur, S D, Reddy, K (2005). Spontaneous unilateral tubal twin pregnancy. JRSM 98: 276-276 [Full Text]  
• Bixby, S., Tello, R., Kuligowska, E. (2005). Presence of a Yolk Sac on Transvaginal Sonography Is the Most Reliable Predictor of Single-Dose Methotrexate Treatment Failure in Ectopic Pregnancy. J Ultrasound Med 24: 591-598 [Abstract] [Full Text]  
• Doubilet, P. M., Benson, C. B., Frates, M. C., Ginsburg, E. (2004). Sonographically Guided Minimally Invasive Treatment of Unusual Ectopic Pregnancies. J Ultrasound Med 23: 359-370 [Abstract] [Full Text]  
• Rozenberg, P., Chevret, S., Camus, E., Tayrac, R. d., Garbin, O., Poncheville, L. d., Coiffic, J., Lucot, J. P., Goueff, F. L., Tardif, D., Allouche, C., Fernandez, H., for the GROG, (2003). Medical treatment of ectopic pregnancies: a randomized clinical trial comparing methotrexate-mifepristone and methotrexate-placebo. Hum Reprod 18: 1802-1808 [Abstract] [Full Text]  
• Coldwell, C. A. (2002). Transvaginal Sonographic Diagnosis of Unilateral Tubal Ectopic Pregnancy in Dichorionic Twins. Journal of Diagnostic Medical Sonography 18: 409-411 [Abstract]  
• Gamzu, R., Almog, B., Levin, Y., Pauzner, D., Lessing, J. B., Jaffa, A., Bar-Am, A. (2002). The ultrasonographic appearance of tubal pregnancy in patients treated with methotrexate. Hum Reprod 17: 2585-2587 [Abstract] [Full Text]  
• Lipscomb, G. H., Stovall, T. G., Ling, F. W. (2000). Nonsurgical Treatment of Ectopic Pregnancy. NEJM 343: 1325-1329 [Full Text]  
• Mol, B. W., Hajenius, P. J., van der Veen, F., Lipscomb, G. H., Ling, F. W. (2000). Predictors of Success of Methotrexate Treatment in Women with Tubal Ectopic Pregnancies. NEJM 342: 1138-1138 [Full Text]  
• (2000). Methotrexate for Tubal Ectopic Pregnancy: Predicting Efficacy. JWatch Women's Health 2000: 5-5 [Full Text]  
• (2000). Predicting the Success of Medical Treatment of Ectopic Pregnancy. JWatch General 2000: 6-6 [Full Text]